McKinley Carter Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,123
Closed -$216K 299
2023
Q1
$216K Hold
3,123
0.02% 285
2022
Q4
$225K Sell
3,123
-351
-10% -$26.5K 0.02% 271
2022
Q3
$247K Buy
3,474
+296
+9% +$21.5K 0.02% 251
2022
Q2
$245K Sell
3,178
-1
-0% -$76 0.02% 265
2022
Q1
$232K Sell
3,179
-209
-6% -$14K 0.02% 268
2021
Q4
$211K Sell
3,388
-2,730
-45% -$160K 0.02% 281
2021
Q3
$362K Sell
6,118
-268
-4% -$17.6K 0.03% 218
2021
Q2
$427K Sell
6,386
-198
-3% -$12.9K 0.04% 205
2021
Q1
$416K Buy
6,584
+82
+1% +$5.1K 0.04% 206
2020
Q4
$403K Buy
+6,502
New +$400K 0.05% 182
2018
Q2
Sell
-250
Closed -$16K 188
2018
Q1
$16K Buy
+250
New +$16.1K 0.01% 343

Other funds holding BMY

McKinley Carter Wealth Services's BMY Position: Q2 2023 in Review

McKinley Carter Wealth Services sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,123 shares — an estimated $216K sold.

McKinley Carter Wealth Services first reported a position in BMY in Q1 2018 and held it in 11 quarters. The position peaked at $427K in Q2 2021. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • McKinley Carter Wealth Services reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 3,123 Bristol-Myers Squibb shares in Q2 2023, an estimated $216K.
  • McKinley Carter Wealth Services first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 11 quarters.
  • McKinley Carter Wealth Services's Bristol-Myers Squibb position peaked at $427K in Q2 2021.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on McKinley Carter Wealth Services's 13F filing for Q2 2023, filed 3 Aug 2023.